Matches in Wikidata for { <http://www.wikidata.org/entity/Q90169248> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q90169248 description "article scientifique publié en 2019" @default.
- Q90169248 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q90169248 description "scientific article published on 27 August 2019" @default.
- Q90169248 description "wetenschappelijk artikel" @default.
- Q90169248 description "наукова стаття, опублікована 27 серпня 2019" @default.
- Q90169248 name "Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy"" @default.
- Q90169248 name "Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy"" @default.
- Q90169248 type Item @default.
- Q90169248 label "Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy"" @default.
- Q90169248 label "Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy"" @default.
- Q90169248 prefLabel "Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy"" @default.
- Q90169248 prefLabel "Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy"" @default.
- Q90169248 P1433 Q90169248-4C1ADA99-6253-48EC-B915-180DD7C1B324 @default.
- Q90169248 P1476 Q90169248-734848CE-AAAE-4572-9564-4FCE2413FE41 @default.
- Q90169248 P2093 Q90169248-1C98D80B-DFCB-4856-BAB8-01A3FCEA415B @default.
- Q90169248 P2093 Q90169248-2AE9095D-0749-43EB-BBBF-2604B89AEBDA @default.
- Q90169248 P2093 Q90169248-45CF3228-C833-47B9-AD6D-6ECD527BF338 @default.
- Q90169248 P2093 Q90169248-85B0E427-4366-4C00-9088-2CCC5F09AA0E @default.
- Q90169248 P2093 Q90169248-9629F01E-3B0E-4E4A-B436-AE6EA6486839 @default.
- Q90169248 P2093 Q90169248-A5A60EAA-55FF-49B0-8BCE-E216A126FE83 @default.
- Q90169248 P2093 Q90169248-CCABAA63-BBCC-40DC-8CA3-4561F6308D76 @default.
- Q90169248 P275 Q90169248-56C2D3C4-4B0C-4C8B-896A-1D935091B850 @default.
- Q90169248 P2860 Q90169248-364180E8-B977-4CFB-BBB3-C2019B541555 @default.
- Q90169248 P304 Q90169248-6F99F85B-ACD2-4515-BDD6-03DACD411F8D @default.
- Q90169248 P31 Q90169248-0239195A-77D3-4104-A184-1C0E9A713C84 @default.
- Q90169248 P31 Q90169248-6AE17745-7AF1-40EF-8D79-38EB1DE0A90A @default.
- Q90169248 P356 Q90169248-23415498-890E-43E0-8873-57C54FD66FD9 @default.
- Q90169248 P478 Q90169248-B7A3708E-EC69-49FF-8BD3-4F05CDEC0C73 @default.
- Q90169248 P50 Q90169248-2EF81A06-E345-4DAA-9CF6-8E0F839CB99B @default.
- Q90169248 P50 Q90169248-360C4F94-16F2-413F-BDF8-CBACC327E090 @default.
- Q90169248 P50 Q90169248-36E92A86-CE74-4CA5-A977-3E67D2F6E6D1 @default.
- Q90169248 P50 Q90169248-E4E8063C-F66A-4273-BF55-1F1700789855 @default.
- Q90169248 P577 Q90169248-6732FC4D-3C1D-46CC-A68E-FDB442812D0B @default.
- Q90169248 P6216 Q90169248-F3AE605B-0ACD-4BFB-86F1-1D0EFD2D9B96 @default.
- Q90169248 P698 Q90169248-70421BDE-F5A4-4AB8-AB21-5AF7DE9E928E @default.
- Q90169248 P921 Q90169248-8C5AE702-21B8-4CE3-9437-CA90C065C349 @default.
- Q90169248 P932 Q90169248-206CE4E1-045A-441B-96AE-48794DCD0E83 @default.
- Q90169248 P356 7608743 @default.
- Q90169248 P698 31534435 @default.
- Q90169248 P1433 Q26841949 @default.
- Q90169248 P1476 "Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy"" @default.
- Q90169248 P2093 "Antje Hoering" @default.
- Q90169248 P2093 "James Chen" @default.
- Q90169248 P2093 "Karla Ballman" @default.
- Q90169248 P2093 "Mark A Dickson" @default.
- Q90169248 P2093 "Rajiv M Patel" @default.
- Q90169248 P2093 "Raphael Pollock" @default.
- Q90169248 P2093 "Suzanne George" @default.
- Q90169248 P275 Q20007257 @default.
- Q90169248 P2860 Q93353436 @default.
- Q90169248 P304 "7608743" @default.
- Q90169248 P31 Q13442814 @default.
- Q90169248 P31 Q1348305 @default.
- Q90169248 P356 "10.1155/2019/7608743" @default.
- Q90169248 P478 "2019" @default.
- Q90169248 P50 Q55576720 @default.
- Q90169248 P50 Q88227829 @default.
- Q90169248 P50 Q89848576 @default.
- Q90169248 P50 Q90169246 @default.
- Q90169248 P577 "2019-08-27T00:00:00Z" @default.
- Q90169248 P6216 Q50423863 @default.
- Q90169248 P698 "31534435" @default.
- Q90169248 P921 Q1504713 @default.
- Q90169248 P932 "6732588" @default.